Operating profit was Y156 million, compared with Y324 million a year earlier. Pretax profit fell to Y171 million from Y325 million. Earnings per share were Y3.36, down from Y13.33.
The results are based on Japanese accounting standards.
In section Market Quotes
Taiko Pharmaceutical Nine-Month Net Profit Falls to Y169 Million
Taiko Pharmaceutical reported net profit of Y169 million for the nine months ended September 30, 2026, down from Y669 million in the same period of 2025. Revenue rose to Y4.59 billion from Y4.23 billion, while operating and pretax profit declined.
Comments (0)
No comments yet. Be the first!